Anxiety Med With Vyvanse

Featured Article

Shire, the maker of Vyvanse, has filed for U.S. approval to treat adult attention-deficit/hyperactivity disorder with their new ADHD medication. Currently the product is approved for children ages 6 to 12 years with ADHD. The company says it has had positive results in their studies treating adults.

Read more

More information on "Anxiety Med With Vyvanse"

From Our Experts

See more SharePosts »

From Our Sources

More on ADHD »